Global Drug Eluting Balloon Catheters Market Size By Product Type, By End-User, By Geographic Scope And Forecast

Drug Eluting Balloon Catheters Market Size And Forecast

Drug Eluting Balloon Catheters Market size was valued at USD 0.61 Billion in 2024 and is projected to reach USD 1.29 Billion by 2031, growing at a CAGR of 10.90% during the forecasted period 2024 to 2031.

Global Drug Eluting Balloon Catheters Market Drivers

The market drivers for the Drug Eluting Balloon Catheters Market can be influenced by various factors. These may include

• Growing Prevalence of Cardiovascular Diseases As cardiovascular disease rates rise around the world, there is a growing need for efficient treatment solutions that can enhance patient outcomes, such as drug-eluting balloon catheters.
• Medical Technology Advancements The effectiveness and uptake of these devices in clinical settings are increased by ongoing improvements in medical technology, such as improved medication formulations and balloon catheter designs.
• Growing Senior Population As people age, they become more vulnerable to cardiovascular diseases, which increases the need for less intrusive treatment options like drug-eluting balloon catheters.
• Growing Preference for Minimally Invasive operations The market is expanding as a result of patients’ and healthcare providers’ growing preference for minimally invasive operations because they offer quicker recovery periods, shorter hospital stays, and less complications.
• Growing Healthcare Expenditure Greater access to cutting-edge medical technologies, such as drug-eluting balloon catheters, is made possible by higher healthcare spending in developed and emerging nations, which promotes market expansion.
• Encouraging Government Policies and Reimbursements The implementation of cutting-edge treatment alternatives such as drug-eluting balloon catheters is facilitated by supportive government policies and payment programmes for cardiovascular treatments.
• Increasing knowledge and Screening Programmes The need for efficient therapeutic devices like drug-eluting balloon catheters is being driven by growing knowledge of cardiovascular health and the benefits of early diagnosis and therapy, which are made possible by the installation of frequent screening programmes.

Global Drug Eluting Balloon Catheters Market Restraints

Several factors can act as restraints or challenges for the Drug Eluting Balloon Catheters Market. These may include

• High Cost Drug-eluting balloon catheters are costly due to their sophisticated production techniques and state-of-the-art technology. For hospitals and patients alike, this high cost can be a major obstacle, particularly in areas with tight healthcare budgets.
• Complicated Regulatory Approval Process Drug-eluting balloon catheters need to go through a rigorous regulatory approval process that can be expensive and time-consuming. Approval delays can prevent new items from entering the market and slow down the uptake of these gadgets.
• Risk of Complications Thrombosis and delayed healing are two possible side effects of drug-eluting balloon catheters, despite their intended reduction of restenosis. Healthcare practitioners may adopt cautiously as a result of these possible hazards.
• Availability of Alternatives Drug-eluting stents and bare-metal stents are two examples of alternative treatments that are available for problems treated with drug-eluting balloon catheters. The growth of the drug-eluting balloon catheter market may be constrained by the presence of these substitutes.
• Problems with Reimbursement Drug-eluting balloon catheter reimbursement regulations are either poorly defined or unfavourable in some areas. This may discourage clinics and hospitals from purchasing these gadgets, which would limit market expansion.
• Lack of Knowledge Patients and healthcare professionals in some poor nations are not well-informed on the advantages of drug-eluting balloon catheters. This may cause these gadgets to be used inefficiently.
• Technological Difficulties Complex technologies are needed in the development and manufacturing of drug-eluting balloon catheters. Technological obstacles or setbacks have the potential to impede market expansion and postpone product debuts.

Global Drug Eluting Balloon Catheters MarketSegmentation Analysis

The Global Drug Eluting Balloon Catheters Market is segmented on the basis of Product Type, End-User, and Geography.

Drug Eluting Balloon Catheters Market, By Product Type

• Coronary Artery Disease
• Peripheral Vascular Disease

Based on Product Type, the market is segmented into Coronary Artery Disease and Peripheral Vascular Disease. This market segment currently holds the majority of the market share for drug-eluting balloon catheters used to treat peripheral vascular disease, and it is expected to continue to expand through 2030 at a CAGR of 10.7% as more healthcare facilities and medical professionals use cutting-edge products to perform complex interventional procedures. These peripheral vascular balloon catheters enhance patient safety during surgical procedures by helping with medicine delivery, limiting the growth of vascular smooth muscle cells during neointimal development, and preventing restenosis.

Drug Eluting Balloon Catheters Market, By End-User

• Hospitals and clinics
• Ambulatory Surgical Centers
• Catheterization Laboratories

Based on End-User, the market is segmented into Hospitals and clinics, Ambulatory Surgical Centers, and Catheterization Laboratories. The market demand is expected to be driven by an increase in the number of in-patient hospital admissions for catheterization treatments as well as a growing desire for minimally invasive operations, which is why the hospital and clinics segment maintained the largest market share by end-use in 2021. The rise in vascular and urological illnesses, arrhythmia, etc., as well as the availability of highly qualified medical and healthcare professionals, are a few of the factors fueling the market expansion.

Drug Eluting Balloon Catheters Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of Regional Analysis, the market is classified into North America, Europe, Asia Pacific, and the Rest of the world. In 2021, North America held a 34.8% revenue share of the market for drug-eluting balloon catheters. The favorable reimbursement environment in the U.S., the expanding desire for minimally invasive procedures, and the soaring number of surgeries are the primary factors boosting the market’s growth in North America. The demand for surgical procedures to address the challenges associated with chronic diseases and injuries is also driving market expansion.

Key Players

The major players in the Drug Eluting Balloon Catheters Market are

• B Braun Melsungen AG
• BD Interventional
• Medtronic
• Aachen Resonance GmbH
• Biosensors International
• Biotronik AG
• Boston Scientific Corporation
• Lepu Medical Technology
• iVascular

Report Scope

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.